Spectrum Pharmaceuticals, Inc.
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES AND EXCHANGE ACT OF 1934

May 15, 2003
Date of Report (Date of earliest event reported)

SPECTRUM PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)
         
Delaware
(State or other Jurisdiction
of Incorporation)		   000-28782
(Commission File Number) 		  93-0979187
(IRS Employer
Identification Number)
         
157 Technology Drive
Irvine, California
(Address of principal executive offices)		       92618
(Zip Code)

(949) 788-6700
(Registrant’s telephone number, including area code)

N/A
(Former Name or Former Address, if Changed Since Last Report)

 

TABLE OF CONTENTS

Item 7. Financial Statements and Exhibits.
Item 9. Regulation FD Disclosure (Information provided under Item 12—Disclosure of Results of Operations and Financial Condition).
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.1

Table of Contents

Item 7.   Financial Statements and Exhibits.

  (c)   Exhibits
         
Exhibits:   Description of Document
 
99.1
   Press Release dated May 15, 2003.

Item 9.   Regulation FD Disclosure (Information provided under Item 12—Disclosure of Results of Operations and Financial Condition).

     Pursuant to Securities and Exchange Commission Release No. 33-8216, dated March 27, 2003, the information provided herein is being furnished under Item 12 of Form 8-K.

     On May 15, 2003, we issued a press release, which sets forth our results of operations for the quarter ended March 31, 2003. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Such information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

2

Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 15, 2003

         
    SPECTRUM PHARMACEUTICALS, INC.
         
    By:   /s/ Michael P. McManus
       
    Name:
Title: 		  Michael P. McManus
Controller

3

Table of Contents

EXHIBIT INDEX

         
Exhibits:   Description of Document
 
99.1
   Press Release dated May 15, 2003.

4